Differential in vitro activity of the DNA topoisomerase inhibitor idarubicin against Trypanosoma rangeli and Trypanosoma cruzi

Jobe, Momodou, Anwuzia-Iwegbu, Charles, Banful, Ama, Bosier, Emma, Iqbal, Mubeen, Jones, Kelly, Lecutier, Suzanne J, Lepper, Kasimir, Redmond, Matt, Ross-Parker, Andrew, Ward, Emily, Wernham, Paul, Whidden, Eleanor M, Tyler, Kevin and Steverding, Dietmar (2012) Differential in vitro activity of the DNA topoisomerase inhibitor idarubicin against Trypanosoma rangeli and Trypanosoma cruzi. Memórias do Instituto Oswaldo Cruz, 107 (7). pp. 946-50. ISSN 1678-8060

Full text not available from this repository. (Request a copy)

Abstract

In this study the effect of eight DNA topoisomerase inhibitors on the growth Trypanosoma rangeli epimastigotes in cell culture was investigated. Among the eight compounds tested, idarubicin was the only compound that displayed promising trypanocidal activity with a half-maximal growth inhibition (GI(50)) value in the sub-micromolar range. Fluorescence-activated cell sorting analysis showed a reduction in DNA content in T. rangeli epimastigotes when treated with idarubicin. In contrast to T. rangeli, against Trypanosoma cruzi epimastigotes idarubicin was much less effective exhibiting a GI(50) value in the mid-micromolar range. This result indicates that idarubicin displays differential toxic effects in T. rangeli and T. cruzi. Compared with African trypanosomes, it seems that American trypanosomes are generally less susceptible to DNA topoisomerase inhibitors.

Item Type: Article
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Pure Connector
Date Deposited: 26 Jun 2013 09:30
Last Modified: 21 Apr 2020 21:46
URI: https://ueaeprints.uea.ac.uk/id/eprint/42526
DOI:

Actions (login required)

View Item View Item